Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

BACKGROUND: Increased mineralocorticoid activity is one of the plausible causes of chronic central serous chorioretinopathy (CSCR) and mineralocorticoid inhibitors such as eplerenone have been investigated as its potential therapy. This study investigates the short-term safety and efficacy of oral e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Retina Vitreous
Hauptverfasser: Moein, Hamid-Reza, Bierman, Lauren W., Novais, Eduardo A., Moreira-Neto, Carlos, Baumal, Caroline R., Rogers, Adam, Duker, Jay S., Witkin, André J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734298/
https://ncbi.nlm.nih.gov/pubmed/31516734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-019-0190-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge